FIM
TCRT icon

Fernwood Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Fernwood Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-67
Closed -$56K – 132
2016
Q3 		$56K Sell
67
-33
-33% -$26.5K 0.05% 122
2016
Q2 		$82K Hold
100
– – 0.08% 116
2016
Q1 		$111K Hold
100
– – 0.11% 112
2015
Q4 		$125K Hold
100
– – 0.11% 117
2015
Q3 		$135K Hold
100
– – 0.12% 109
2015
Q2 		$180K Hold
100
– – 0.14% 110
2015
Q1 		$162K Buy
+100
New +$148K 0.13% 108

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fernwood Investment Management's TCRT Position: Q4 2016 in Review

Fernwood Investment Management sold out of Alaunos Therapeutics (TCRT) in Q4 2016, closing a stake of 67 shares — an estimated $56K sold.

Fernwood Investment Management first reported a position in TCRT in Q1 2015 and held it in 7 quarters. The position peaked at $180K in Q2 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • Fernwood Investment Management reported no remaining Alaunos Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Fernwood Investment Management sold 67 Alaunos Therapeutics shares in Q4 2016, an estimated $56K.
  • Fernwood Investment Management first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 7 quarters.
  • Fernwood Investment Management's Alaunos Therapeutics position peaked at $180K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on Fernwood Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.